HBI
31
-6
CF
41
2
SRE
56
2
MCHP
51
6
IPG
53
3
HSY
51
-2
XOM
42
3
LLY
60
-14
CL
50
-8
AFL
44
-2
GILD
63
-4
AN
58
4
BEN
29
4
STI
36
3
JNPR
54
2
BRK.B
40
-2
MHK
50
4
ADT
38
3
IVZ
45
2
DTE
75
3
HBI
31
-6
CF
41
2
SRE
56
2
MCHP
51
6
IPG
53
3
HSY
51
-2
XOM
42
3
LLY
60
-14
CL
50
-8
AFL
44
-2
GILD
63
-4
AN
58
4
BEN
29
4
STI
36
3
JNPR
54
2
BRK.B
40
-2
MHK
50
4
ADT
38
3
IVZ
45
2
DTE
75
3
Financhill
Back

Viatris Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
40

VTRS
Viatris

Last Price:
$10.8000
Seasonality Move:
0.96%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$107.93
Seasonality Move:
1.75%
Sell
40
Viatris (VTRS) is a Sell

Is Viatris a Buy, Sell or Hold?

  • The current Viatris [VTRS] share price is $10.8000. The Score for VTRS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • VTRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VTRS Stock Price Chart

What is Viatris's stock price today?

  • The Viatris share price today is $10.8000
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VTRS is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

VTRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 35.64 Sell
Chaikin Money Flow: -7974687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.8048 - 11.4848) Sell
Bollinger Bands (100): (11.1877 - 12.7077) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

VTRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.75 Buy
20-day SMA: 11.04 Sell
50-day SMA: 11.82 Sell
200-day SMA: 11.59 Sell
8-day EMA: 10.8 Buy
20-day EMA: 11.06 Sell
50-day EMA: 11.55 Sell
200-day EMA: 11.64 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Viatris Earnings Growth & VTRS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $0.12 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Viatris Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):